These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33777736)

  • 1. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma.
    Song T; Li L; Wu S; Liu Y; Guo C; Wang W; Dai L; Zhang T; Wu H; Su B
    Front Oncol; 2021; 11():583714. PubMed ID: 33777736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
    Chen T
    J Hepatocell Carcinoma; 2022; 9():1029-1040. PubMed ID: 36132427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Zeng Y; Hu S; Luo Y; He K
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCC biomarkers - state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice.
    Schlosser S; Tümen D; Volz B; Neumeyer K; Egler N; Kunst C; Tews HC; Schmid S; Kandulski A; Müller M; Gülow K
    Front Oncol; 2022; 12():1016952. PubMed ID: 36518320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
    Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
    Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
    Liu WH; Ren LN; Wang X; Wang T; Zhang N; Gao Y; Luo H; Navarro-Alvarez N; Tang LJ
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
    Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional role of exosome in hepatocellular carcinoma.
    Liu H; Li B
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2085-2095. PubMed ID: 30062486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cell free DNA in the diagnosis of HCC.
    Banini BA; Sanyal AJ
    Hepatoma Res; 2019; 5():. PubMed ID: 31673629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Circular RNAs in Different Types of Samples for Detecting Hepatocellular Carcinoma: A Meta-Analysis.
    Nie G; Peng D; Li B; Lu J; Xiong X
    Front Genet; 2021; 12():794105. PubMed ID: 34992634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.
    Cerrito L; Ainora ME; Mosoni C; Borriello R; Gasbarrini A; Zocco MA
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.